These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 16321460)

  • 1. Sequence constancies and variations in genes encoding three new meningococcal vaccine candidate antigens.
    Jacobsson S; Thulin S; Mölling P; Unemo M; Comanducci M; Rappuoli R; Olcén P
    Vaccine; 2006 Mar; 24(12):2161-8. PubMed ID: 16321460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and sequence variations of the genes encoding the five antigens included in the novel 5CVMB vaccine covering group B meningococcal disease.
    Jacobsson S; Hedberg ST; Mölling P; Unemo M; Comanducci M; Rappuoli R; Olcén P
    Vaccine; 2009 Mar; 27(10):1579-84. PubMed ID: 19162117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of vaccine potential of the Neisseria-specific protein NMB0938.
    Sardiñas G; Climent Y; Rodríguez Y; González S; García D; Cobas K; Caballero E; Pérez Y; Brookes C; Taylor S; Gorringe A; Delgado M; Pajón R; Yero D
    Vaccine; 2009 Nov; 27(49):6910-7. PubMed ID: 19751688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic shifts of Neisseria meningitidis serogroup B antigens and the quest for a broadly cross-protective vaccine.
    Bai X; Borrow R
    Expert Rev Vaccines; 2010 Oct; 9(10):1203-17. PubMed ID: 20923270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody to genome-derived neisserial antigen 2132, a Neisseria meningitidis candidate vaccine, confers protection against bacteremia in the absence of complement-mediated bactericidal activity.
    Welsch JA; Moe GR; Rossi R; Adu-Bobie J; Rappuoli R; Granoff DM
    J Infect Dis; 2003 Dec; 188(11):1730-40. PubMed ID: 14639545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel meningococcal 4CMenB vaccine antigens - prevalence and polymorphisms of the encoding genes in Neisseria gonorrhoeae.
    Hadad R; Jacobsson S; Pizza M; Rappuoli R; Fredlund H; Olcén P; Unemo M
    APMIS; 2012 Sep; 120(9):750-60. PubMed ID: 22882265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequence conservation of pilus subunits in Neisseria meningitidis.
    Cehovin A; Winterbotham M; Lucidarme J; Borrow R; Tang CM; Exley RM; Pelicic V
    Vaccine; 2010 Jul; 28(30):4817-26. PubMed ID: 20457291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of new meningococcal serogroup B surface antigens through a systematic analysis of neisserial genomes.
    Pajon R; Yero D; Niebla O; Climent Y; Sardiñas G; García D; Perera Y; Llanes A; Delgado M; Cobas K; Caballero E; Taylor S; Brookes C; Gorringe A
    Vaccine; 2009 Dec; 28(2):532-41. PubMed ID: 19837092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution and genetic variability of three vaccine components in a panel of strains representative of the diversity of serogroup B meningococcus.
    Bambini S; Muzzi A; Olcen P; Rappuoli R; Pizza M; Comanducci M
    Vaccine; 2009 May; 27(21):2794-803. PubMed ID: 19428890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequence diversity of the factor H binding protein vaccine candidate in epidemiologically relevant strains of serogroup B Neisseria meningitidis.
    Murphy E; Andrew L; Lee KL; Dilts DA; Nunez L; Fink PS; Ambrose K; Borrow R; Findlow J; Taha MK; Deghmane AE; Kriz P; Musilek M; Kalmusova J; Caugant DA; Alvestad T; Mayer LW; Sacchi CT; Wang X; Martin D; von Gottberg A; du Plessis M; Klugman KP; Anderson AS; Jansen KU; Zlotnick GW; Hoiseth SK
    J Infect Dis; 2009 Aug; 200(3):379-89. PubMed ID: 19534597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective activity of monoclonal antibodies to genome-derived neisserial antigen 1870, a Neisseria meningitidis candidate vaccine.
    Welsch JA; Rossi R; Comanducci M; Granoff DM
    J Immunol; 2004 May; 172(9):5606-15. PubMed ID: 15100304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meningococcal protein antigens and vaccines.
    Feavers IM; Pizza M
    Vaccine; 2009 Jun; 27 Suppl 2():B42-50. PubMed ID: 19481315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent developments in vaccines to prevent meningococcal serogroup B infections.
    Vermont CL; van den Dobbelsteen GP; de Groot R
    Curr Opin Mol Ther; 2003 Feb; 5(1):33-8. PubMed ID: 12669468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid genetic grouping of factor h-binding protein (genome-derived neisserial antigen 1870), a promising group B meningococcal vaccine candidate.
    Beernink PT; Leipus A; Granoff DM
    Clin Vaccine Immunol; 2006 Jul; 13(7):758-63. PubMed ID: 16829612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein NMB0928 from Neisseria meningitidis serogroup B as a novel vaccine candidate.
    Delgado M; Yero D; Niebla O; González S; Climent Y; Pérez Y; Cobas K; Caballero E; García D; Pajón R
    Vaccine; 2007 Dec; 25(50):8420-31. PubMed ID: 17996338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and genetic diversity of candidate vaccine antigens among invasive Neisseria meningitidis isolates in the United States.
    Wang X; Cohn A; Comanducci M; Andrew L; Zhao X; MacNeil JR; Schmink S; Muzzi A; Bambini S; Rappuoli R; Pizza M; Murphy E; Hoiseth SK; Jansen KU; Anderson AS; Harrison LH; Clark TA; Messonnier NE; Mayer LW
    Vaccine; 2011 Jun; 29(29-30):4739-44. PubMed ID: 21571026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postgenomics of Neisseria meningitidis for vaccines development.
    Bernardini G; Braconi D; Martelli P; Santucci A
    Expert Rev Proteomics; 2007 Oct; 4(5):667-77. PubMed ID: 17941821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance.
    Madico G; Welsch JA; Lewis LA; McNaughton A; Perlman DH; Costello CE; Ngampasutadol J; Vogel U; Granoff DM; Ram S
    J Immunol; 2006 Jul; 177(1):501-10. PubMed ID: 16785547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humans.
    Serruto D; Spadafina T; Ciucchi L; Lewis LA; Ram S; Tontini M; Santini L; Biolchi A; Seib KL; Giuliani MM; Donnelly JJ; Berti F; Savino S; Scarselli M; Costantino P; Kroll JS; O'Dwyer C; Qiu J; Plaut AG; Moxon R; Rappuoli R; Pizza M; Aricò B
    Proc Natl Acad Sci U S A; 2010 Feb; 107(8):3770-5. PubMed ID: 20133713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic Surveillance of 4CMenB Vaccine Antigenic Variants among Disease-Causing Neisseria meningitidis Isolates, United Kingdom, 2010-2016.
    Rodrigues CMC; Lucidarme J; Borrow R; Smith A; Cameron JC; Moxon ER; Maiden MCJ
    Emerg Infect Dis; 2018 Apr; 24(4):673-682. PubMed ID: 29553330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.